Clinical Trial

Exercise Capacity Improvement by Conduction System Pacing in heArt Failure patieNts Without Compelling CRT inDication

Study acronym: ESCPAND
Recruiting
View on ClinicalTrials.gov →
Summary
This randomized controlled trial aims to investigate the impact of conduction system pacing in comparison to right ventricular apical pacing on exercise capacity, as measured by peak oxygen uptake (VO2peak), in heart failure patients with indication for pacing but no compelling indication for cardiac resynchronization therapy (CRT). The mechanisms of exercise intolerance in heart failure patients influenced by conduction system pacing will be assessed.
Trial Details
NCT Number NCT06278844
Lead Sponsor University Hospital, Antwerp
Conditions Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Heart Conduction Disorder
Enrollment 75 participants
Start Date 2023-12-12
Primary Completion 2026-09 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2024-02-26